PAIDLATE
← New check

Their own payment-practices filing · gov.uk

Bristol-Myers Squibb Pharmaceuticals Limited pays suppliers in 50 days on average — inside its 90-day stated terms

CRN 02487574 · Manufacturing · 15 statutory reports on record · period to 30 Jun 2026

50daysavg time to pay · H1 2026

Their H1 2026 filing puts the average 40 days inside their stated 90-day term.

Slower than mostvs a 31-day median across 6,104 recent filers
Their stated terms
90 days
Paid outside agreed terms
21% of invoices
Paid after 61+ days
37%
Reporting period
1 Jan 2026 – 30 Jun 2026
Source
their gov.uk filing, filed 17 Aug 2026

Self-reported figures from their statutory filing. How this is compiled.

Terms vs reality · their H1 2026 filing

Paid 40 days inside the 90-day term they state

The pattern · last 6 of 15 reports

40 → 50 days — slowing down

The read · computed from their figures

Bristol-Myers Squibb Pharmaceuticals Limited's H1 2026 filing puts their average at 50 days against stated terms of 90 days; 21% of invoices were paid outside agreed terms and 37% took 61 days or longer. Filed 17 Aug 2026.

The direction is slower: from 40 days in H2 2022 to 50 now — 10 days slower across their last 6 reports.

On the latest reported averages: Slower than 59% of the 977 large companies reporting in manufacturing.

That is 15 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.

What they tell their suppliers

Offers e-invoicing 84% of invoices in dispute

In their own words · from the filing

Standard payment terms

The preferred BMS terms for 3rd party vendors are default to 90 days. Payment terms are outlined in contracts with suppliers. Where a contract is not negotiated, the payment terms will be clearly stated on the Purchase Orders (POs) sent to suppliers. Any changes to the payment terms would require a contract amendment. For Health Care Professionals the standard payment terms are immediate, therefore meeting these terms are difficult to achieve when we consider time to send the invoice, process, approve and release for payment, currently 73% of the above reported late payments are due to Immediate payment terms. Intercompany transactions may also negatively impact the On-time payment percentage due to the Intercompany monthly netting schedule (a further 11% of late payments).

Dispute resolution

BMS has a dedicated Accounts Payable helpdesk in the event of a dispute with a supplier that offers them support through to query resolution. This query can be raised via email at [email protected]. If needed the query is then forwarded to the BMS contact (contract monitor or requisitioner) for further investigation.

Every statutory report on record

Most recent first.

PeriodAvg daysOutside terms61+ daysFiled
H1 20265021%37%17 Aug 2026
H2 20254522%29%10 Feb 2026
H1 20255022%31%28 Jul 2025
H2 20234227%22%30 Jan 2024
H1 20234227%21%20 Jul 2023
H2 20224024%20%27 Jan 2023
H1 20224027%21%15 Jul 2022
H2 20214028%22%31 Jan 2022
H1 20214628%33%29 Jul 2021
H2 20204131%27%29 Jan 2021
H1 20204531%32%31 Jul 2020
H2 20193836%20%30 Jan 2020
H1 20194140%30%19 Jul 2019
H2 20184134%24%25 Jan 2019
H1 20183940%25%30 Jul 2018

On the public register · Companies House

Company record

Status
Active
Type
Private Limited Company
Incorporated
2 Apr 1990
Registered office
ARC UXBRIDGE SANDERSON ROAD, DENHAM, UB8 1DH
0 outstanding charges on the register Accounts due 30 Sept 2027

Open the full record at Companies House.

Quick answers · Bristol-Myers Squibb Pharmaceuticals Limited

Are they getting slower or faster?
Their reported average has moved about 10 days slower over the window (40 → 50 days).
What's their typical pay point?
Their latest filed report puts the average at day 50; across their last 6 reports it ranged 40–50 days. Treat that as a historical reference point, not a promise for a new invoice.
Can I see what this means for my invoices?
Run the live check — it re-reads their record and their live Companies House file, on the amount you invoice.
Share

Stay ahead

Watch Bristol-Myers Squibb Pharmaceuticals Limited (free)

Their next payment report is due ≈ 26 Jan 2027. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.

You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.

More large companies in manufacturing

Brintons Carpets Limited · Britannia Refined Metals Limited · Brindleclass Limited · British Airways Maintenance Cardiff Limited · Briggs of Burton PLC · British American Tobacco Western Europe Commercial Trading Limited

How UK payment reporting works

What is a Payment Practices Report?
UK companies and LLPs above a size threshold — broadly, two of: turnover over £54m, balance sheet over £27m, or more than 250 employees — must report twice a year, under the Reporting on Payment Practices and Performance Regulations 2017, how quickly they actually pay suppliers: the average time to pay, the share of invoices paid in 30 days or fewer, 31 to 60 days and 61 days or longer, and their standard payment terms. Those thresholds apply to financial years beginning on or after 6 April 2025; for earlier financial years they were £36m and £18m, with the same 250-employee test.
What does "paid outside agreed terms" mean?
The share of invoices paid later than the terms in the supplier contract. If terms are 30 days and an invoice is paid on day 45, it counts as paid outside terms, regardless of the headline average.
How often is this data updated?
Each report covers a six-month period and must be filed within 30 days of that period ending, so a company's record refreshes roughly twice a year. PaidLate re-reads the register as new reports are filed.
Is this official government data?
The underlying payment figures come from the company's own statutory filings on the gov.uk payment-practices service; company-status data comes from Companies House. PaidLate calculates trends, comparisons and summaries from those records. It does not use surveys or credit-agency scores.

How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.

The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).

Report PL-02487574 · latest period to 30 Jun 2026

Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.